review article | Q7318358 |
scholarly article | Q13442814 |
P2093 | author name string | Green WR | |
P304 | page(s) | 27 | |
P577 | publication date | 1999-11-03 | |
P1433 | published in | Molecular Vision | Q6895981 |
P1476 | title | Histopathology of age-related macular degeneration | |
P478 | volume | 5 |
Q35553055 | A comparison of some organizational characteristics of the mouse central retina and the human macula |
Q39128040 | A2E induces IL-1ß production in retinal pigment epithelial cells via the NLRP3 inflammasome |
Q35126780 | Age-Related Macular Degeneration: Etiology, Pathogenesis, and Therapeutic Strategies |
Q82698020 | Age-related macular degeneration |
Q38221023 | Age-related macular degeneration and changes in the extracellular matrix |
Q33911009 | Age-related macular degeneration: a high-resolution genome scan for susceptibility loci in a population enriched for late-stage disease |
Q34588628 | Age-related macular degeneration: insights into inflammatory genes |
Q33961165 | Age-related susceptibility to apoptosis in human retinal pigment epithelial cells is triggered by disruption of p53-Mdm2 association |
Q37315838 | Aging is not a disease: distinguishing age-related macular degeneration from aging |
Q96135356 | Angiogenesis in Breast Cancer Progression, Diagnosis, and Treatment |
Q34604781 | Angiogenin in age-related macular degeneration |
Q35071068 | Angiotensin II-induced MMP-2 activity and MMP-14 and basigin protein expression are mediated via the angiotensin II receptor type 1-mitogen-activated protein kinase 1 pathway in retinal pigment epithelium: implications for age-related macular degene |
Q37347557 | Angiotensin II-induced hypertension regulates AT1 receptor subtypes and extracellular matrix turnover in mouse retinal pigment epithelium |
Q34251889 | Angiotensin II-related hypertension and eye diseases |
Q27004686 | Animal models of age related macular degeneration |
Q33920123 | Apolipoprotein E allele-dependent pathogenesis: a model for age-related retinal degeneration |
Q33999935 | Aqueous interleukin-6 levels are superior to vascular endothelial growth factor in predicting therapeutic response to bevacizumab in age-related macular degeneration |
Q30884052 | Atrial natriuretic peptide reduces vascular leakage and choroidal neovascularization |
Q37558259 | Beyond VEGF-The Weisenfeld Lecture |
Q41531438 | Biochemical Measurements of Free Opsin in Macular Degeneration Eyes: Examining the 11-CIS Retinal Deficiency Hypothesis of Delayed Dark Adaptation (An American Ophthalmological Society Thesis). |
Q90207070 | Blockade of insulin receptor substrate-1 inhibits biological behavior of choroidal endothelial cells |
Q55280228 | Characterization of Human iPSC-RPE on a Prosthetic Bruch's Membrane Manufactured From Silk Fibroin. |
Q21260371 | Cholesterol-enriched diet causes age-related macular degeneration-like pathology in rabbit retina |
Q34086893 | Cigarette smoke-related hydroquinone induces filamentous actin reorganization and heat shock protein 27 phosphorylation through p38 and extracellular signal-regulated kinase 1/2 in retinal pigment epithelium: implications for age-related macular deg |
Q34642583 | Clinical and differential utility of VEGF inhibitors in wet age-related macular degeneration: focus on aflibercept |
Q44421126 | Clinicopathological correlation of choroidal neovascularization after external beam radiotherapy in age-related macular degeneration |
Q64246931 | Comparison of histologic findings in age-related macular degeneration with RPE flatmount images |
Q34735128 | Complement component C5a activates ICAM-1 expression on human choroidal endothelial cells |
Q35908535 | Detection of CX3CR1 single nucleotide polymorphism and expression on archived eyes with age-related macular degeneration |
Q33645725 | Development of choroidal neovascularization in rats with advanced intense cyclic light-induced retinal degeneration |
Q35591390 | Differential expression of GFAP in early v late AMD: a quantitative analysis |
Q42514513 | Drusen in patient-derived hiPSC-RPE models of macular dystrophies. |
Q37395303 | Dry age-related macular degeneration: mechanisms, therapeutic targets, and imaging |
Q33585812 | Early AMD-like defects in the RPE and retinal degeneration in aged mice with RPE-specific deletion of Atg5 or Atg7 |
Q99565098 | Early Ophthalmic Changes in Macula Does Not Correlate with Visual Function |
Q42086363 | Effect of change in drusen evolution on photoreceptor inner segment/outer segment junction |
Q40812272 | Effect of lutein and antioxidant supplementation on VEGF expression, MMP-2 activity, and ultrastructural alterations in apolipoprotein E-deficient mouse. |
Q90713522 | Effects of bevacizumab, ranibizumab, and aflibercept on phagocytic properties in human RPE cybrids with AMD versus normal mitochondria |
Q35220964 | Effects of subretinal electrical stimulation in mer-KO mice |
Q37028518 | Elastin-mediated choroidal endothelial cell migration: possible role in age-related macular degeneration |
Q37211031 | Expression of Robo4 in the fibrovascular membranes from patients with proliferative diabetic retinopathy and its role in RF/6A and RPE cells. |
Q50205666 | Functional and morphological evaluation of blue light-emitting diode-induced retinal degeneration in mice |
Q36405448 | Genetic mechanisms and age-related macular degeneration: common variants, rare variants, copy number variations, epigenetics, and mitochondrial genetics |
Q41910590 | Ginsenoside-Rb1 Induces ARPE-19 Proliferation and Reduces VEGF Release |
Q34565911 | High-sensitivity C-reactive protein, other markers of inflammation, and the incidence of macular degeneration in women |
Q36481880 | Human HtrA1 in the archived eyes with age-related macular degeneration |
Q38432020 | Identification of pathogenic genes and upstream regulators in age-related macular degeneration |
Q36962720 | Improved cell metabolism prolongs photoreceptor survival upon retinal-pigmented epithelium loss in the sodium iodate induced model of geographic atrophy |
Q93151000 | Improving visible light OCT of the human retina with rapid spectral shaping and axial tracking |
Q35119433 | Inhibition of APE1/Ref-1 redox activity rescues human retinal pigment epithelial cells from oxidative stress and reduces choroidal neovascularization |
Q41191124 | Inhibition of proliferation of retinal vascular endothelial cells more effectively than choroidal vascular endothelial cell proliferation by bevacizumab |
Q35761920 | Localisation of SDF-1 and its receptor CXCR4 in retina and choroid of aged human eyes and in eyes with age related macular degeneration |
Q34733171 | Long term effects of lutein, zeaxanthin and omega-3-LCPUFAs supplementation on optical density of macular pigment in AMD patients: the LUTEGA study |
Q35902212 | Long-Term Visual Outcomes for a Treat and Extend Anti-Vascular Endothelial Growth Factor Regimen in Eyes with Neovascular Age-Related Macular Degeneration |
Q92126280 | Low incidence of pachydrusen in central serous chorioretinopathy in an Indian cohort |
Q37461049 | Low nitric oxide synthases (NOSs) in eyes with age-related macular degeneration (AMD). |
Q38173896 | Mechanism of inflammation in age-related macular degeneration: an up-to-date on genetic landmarks. |
Q30912692 | Microglia in the mouse retina alter the structure and function of retinal pigmented epithelial cells: a potential cellular interaction relevant to AMD. |
Q26823440 | Microglia in the outer retina and their relevance to pathogenesis of age-related macular degeneration |
Q37066074 | Modulation of choroidal neovascularization by subretinal injection of retinal pigment epithelium and polystyrene microbeads. |
Q37273740 | Molecular pathology of age-related macular degeneration |
Q39426754 | Molecular responses of choroidal endothelial cells to elastin derived peptides through the elastin-binding protein (GLB1). |
Q43006634 | Mouse models may provide new insight into the relation between cholesterol and age related macular degeneration |
Q36102995 | Murine ccl2/cx3cr1 deficiency results in retinal lesions mimicking human age-related macular degeneration. |
Q93387980 | Negative Regulators of Angiogenesis, Ocular Vascular Homeostasis, and Pathogenesis and Treatment of Exudative AMD |
Q39416208 | Negative regulators of angiogenesis: important targets for treatment of exudative AMD. |
Q35027712 | Nicotine increases the VEGF/PEDF ratio in retinal pigment epithelium: a possible mechanism for CNV in passive smokers with AMD |
Q49918278 | PEDF Expression Affects the Oxidative and Inflammatory State of Choroidal Endothelial Cells |
Q93017085 | Pachydrusen in polypoidal choroidal vasculopathy in an Indian cohort |
Q36918766 | Pegaptanib in the treatment of wet, age-related macular degeneration |
Q36446030 | Peroxisome proliferator-activated receptor and age-related macular degeneration |
Q37226519 | Photoreceptor layer thinning over drusen in eyes with age-related macular degeneration imaged in vivo with spectral-domain optical coherence tomography |
Q37064822 | Pigment epithelium-derived factor (PEDF) and vascular endothelial growth factor (VEGF) in aged human choroid and eyes with age-related macular degeneration |
Q73011051 | Pigment epithelium-derived factor supports normal development of photoreceptor neurons and opsin expression after retinal pigment epithelium removal |
Q36517811 | Prevalence and morphology of druse types in the macula and periphery of eyes with age-related maculopathy |
Q35789316 | Progressive age-related changes similar to age-related macular degeneration in a transgenic mouse model |
Q37379603 | Proteomics characterization of cell membrane blebs in human retinal pigment epithelium cells |
Q40034168 | Quercetin inhibits choroidal and retinal angiogenesis in vitro |
Q36016325 | Receptor tyrosine kinase inhibitors AG013764 and AG013711 reduce choroidal neovascularization in rat eye. |
Q35740328 | Regulation of age-related macular degeneration-like pathology by complement factor H. |
Q37016739 | Regulation of angiotensin II receptors and extracellular matrix turnover in human retinal pigment epithelium: role of angiotensin II |
Q36067442 | Research resource: nuclear receptor atlas of human retinal pigment epithelial cells: potential relevance to age-related macular degeneration |
Q26771160 | Retinal Cell Degeneration in Animal Models |
Q35083382 | Retinal dystrophy resulting from ablation of RXR alpha in the mouse retinal pigment epithelium |
Q37071181 | Retinal pigment epithelial cell proliferation |
Q34702697 | Retinal pigment epithelium protection from oxidant-mediated loss of MMP-2 activation requires both MMP-14 and TIMP-2. |
Q33787737 | Retinal ultrastructure of murine models of dry age-related macular degeneration (AMD). |
Q27330479 | Retinotopic Distribution of Structural and Functional Damages following Bright Light Exposure of Juvenile Rats |
Q38975099 | Risk of geographic atrophy in age-related macular degeneration patients treated with intravitreal anti-VEGF agents |
Q35003936 | Risk of geographic atrophy in the comparison of age-related macular degeneration treatments trials |
Q64241468 | Soluble Epoxide Hydrolase Inhibition for Ocular Diseases: Vision for the Future |
Q36143737 | Spare the rod and spoil the eye. |
Q30410747 | Spectral-domain optical coherence tomography findings in polypoidal choroidal vasculopathy suggest a type 1 neovascular growth pattern |
Q36693179 | Subtype specific estrogen receptor action protects against changes in MMP-2 activation in mouse retinal pigmented epithelial cells |
Q36350410 | Suggestive association between PLA2G12A single nucleotide polymorphism rs2285714 and response to anti-vascular endothelial growth factor therapy in patients with exudative age-related macular degeneration. |
Q51735584 | Targeting Hif1a rescues cone degeneration and prevents subretinal neovascularization in a model of chronic hypoxia. |
Q34175235 | The influence of substrate elastic modulus on retinal pigment epithelial cell phagocytosis. |
Q33206080 | The relative contributions of each subset of ocular infiltrated cells in experimental choroidal neovascularisation |
Q26865643 | Today and future of age-related macular degeneration |
Q35007241 | Transcriptional factors associated with epithelial-mesenchymal transition in choroidal neovascularization. |
Q42221474 | Treatment of dry age-related macular degeneration with dobesilate |
Q36311846 | Unraveling a multifactorial late-onset disease: from genetic susceptibility to disease mechanisms for age-related macular degeneration |
Q41762748 | Vascular endothelial growth factor gene polymorphisms in age-related macular degeneration in a Turkish population |
Q33722131 | Viewing Ageing Eyes: Diverse Sites of Amyloid Beta Accumulation in the Ageing Mouse Retina and the Up-Regulation of Macrophages |
Q34007850 | Vitamin A dimers trigger the protracted death of retinal pigment epithelium cells |
Q52314263 | Volume-Rendered Projection-Resolved OCT Angiography: 3D Lesion Complexity Is Associated With Therapy Response in Wet Age-Related Macular Degeneration. |
Q90249957 | Wnt Signaling in vascular eye diseases |
Search more.